Cranston Lynda Sarah 4
4 · DelMar Pharmaceuticals, Inc. · Filed Apr 1, 2019
Insider Transaction Report
Form 4
Cranston Lynda Sarah
Director
Transactions
- Other
Common Stock
2019-03-29$0.49/sh+71$35→ 2,912 total(indirect: Held by J.G. Cranston & Associates, Inc.)
Footnotes (1)
- [F1]The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.